207 related articles for article (PubMed ID: 23320475)
1. Clinical efficacy of the GnRH agonist (deslorelin) in dogs affected by benign prostatic hyperplasia and evaluation of prostatic blood flow by Doppler ultrasound.
Polisca A; Orlandi R; Troisi A; Brecchia G; Zerani M; Boiti C; Zelli R
Reprod Domest Anim; 2013 Aug; 48(4):673-80. PubMed ID: 23320475
[TBL] [Abstract][Full Text] [Related]
2. Power and pulsed Doppler evaluation of prostatic artery blood flow in normal and benign prostatic hyperplasia-affected dogs.
Zelli R; Orlandi R; Troisi A; Cardinali L; Polisca A
Reprod Domest Anim; 2013 Oct; 48(5):768-73. PubMed ID: 23505997
[TBL] [Abstract][Full Text] [Related]
3. [Development of a large intraprostatic cyst following the use of a GnRH agonist-implant in a male dog with benign prostatic hyperplasia].
Socha P; Janowski T; Zduńczyk S
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2020 Dec; 48(6):443-446. PubMed ID: 33276394
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the clinical efficacy of Gonazon implants in the treatment of reproductive pathologies, behavioral problems, and suppression of reproductive function in the male dog.
Goericke-Pesch S; Wilhelm E; Ludwig C; Desmoulins PO; Driancourt MA; Hoffmann B
Theriogenology; 2010 Apr; 73(7):920-6. PubMed ID: 20097413
[TBL] [Abstract][Full Text] [Related]
5. Effects of benign prostatic hyperplasia and finasteride therapy on prostatic blood flow in dogs.
Angrimani DSR; Silvestrini GR; Brito MM; Abreu RA; Almeida LL; Vannucchi CI
Theriogenology; 2018 Jul; 114():103-108. PubMed ID: 29605575
[TBL] [Abstract][Full Text] [Related]
6. Quantitative bidimentional and Doppler ultrasound assessment of the effect of a GnRH antagonist on canine prostatic hyperplasia.
D'Francisco F; Merlo ML; Lapuente C; Blasco A; Gobello C
Theriogenology; 2020 Mar; 144():41-44. PubMed ID: 31901534
[TBL] [Abstract][Full Text] [Related]
7. Arterial ovarian blood flow in the periovulatory period of GnRH-induced and spontaneous estrous cycles of bitches.
Jurczak A; Janowski T
Theriogenology; 2018 Oct; 119():131-136. PubMed ID: 30006128
[TBL] [Abstract][Full Text] [Related]
8. Semen quality and onset of sterility following administration of a 4.7-mg deslorelin implant in adult male dogs.
Romagnoli S; Siminica A; Sontas BH; Milani C; Mollo A; Stelletta C
Reprod Domest Anim; 2012 Dec; 47 Suppl 6():389-92. PubMed ID: 23279546
[TBL] [Abstract][Full Text] [Related]
9. Chronic use of a GnRH agonist (deslorelin) or immunization against GnRH: effects on testicular function and sperm quality of bucks.
Giriboni J; Lacuesta L; Santiago-Moreno J; Ungerfeld R
Domest Anim Endocrinol; 2020 Apr; 71():106395. PubMed ID: 31731252
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic administration of a highly potent LHRH agonist on prostate size and secretory function in geriatric dogs.
Vickery BH; McRae GI; Bonasch H
Prostate; 1982; 3(2):123-30. PubMed ID: 6178098
[TBL] [Abstract][Full Text] [Related]
11. Effect of pulsed electromagnetic field therapy on prostate volume and vascularity in the treatment of benign prostatic hyperplasia: a pilot study in a canine model.
Leoci R; Aiudi G; Silvestre F; Lissner E; Lacalandra GM
Prostate; 2014 Aug; 74(11):1132-41. PubMed ID: 24913937
[TBL] [Abstract][Full Text] [Related]
12. [GnRH agonist implants in small animal practice - what do we know 13 years following EU registration?].
Stempel S; Goericke-Pesch S
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2020 Dec; 48(6):420-432. PubMed ID: 33276392
[TBL] [Abstract][Full Text] [Related]
13. Basal testosterone concentrations after the application of a slow-release GnRH agonist implant are associated with a loss of response to buserelin, a short-term GnRH agonist, in the tom cat.
Goericke-Pesch S; Georgiev P; Fasulkov I; Vodenicharov A; Wehrend A
Theriogenology; 2013 Jul; 80(1):65-9. PubMed ID: 23622940
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of chlormadinone acetate-pellet implantation and orchidectomy on benign prostatic hypertrophy in the dog.
Kawakami E; Tsutsui T; Shimizu M; Orima H; Fujita M; Ogasa A
Int J Androl; 1995 Oct; 18(5):248-55. PubMed ID: 8567095
[TBL] [Abstract][Full Text] [Related]
15. Delay of puberty and reproductive performance in male dogs following the implantation of 4.7 and 9.4 mg GnRH-agonist deslorelin at an early pre-pubertal age.
Sirivaidyapong S; Mehl NS; Trigg TE
Reprod Domest Anim; 2012 Dec; 47 Suppl 6():400-2. PubMed ID: 23279549
[TBL] [Abstract][Full Text] [Related]
16. Blood dripping from the penis of a German Shepherd dog.
Sontas BH; Milani C; Mollo A; Romagnoli S
Aust Vet J; 2010 Jun; 88(6):242-4. PubMed ID: 20553576
[No Abstract] [Full Text] [Related]
17. Dose-response studies for pituitary and testicular function in male dogs treated with the GnRH superagonist, deslorelin.
Junaidi A; Williamson PE; Martin GB; Blackberry MA; Cummins JM; Trigg TE
Reprod Domest Anim; 2009 Oct; 44(5):725-34. PubMed ID: 19769638
[TBL] [Abstract][Full Text] [Related]
18. Effects of implants containing the GnRH agonist deslorelin on testosterone release and semen characteristics in Shetland stallions.
Gautier C; Schmidt K; Aurich J; Aurich C
Anim Reprod Sci; 2018 Aug; 195():230-241. PubMed ID: 29859702
[TBL] [Abstract][Full Text] [Related]
19. Azoospermia with variable testicular histology after 7 months of treatment with a deslorelin implant in toms.
Novotny R; Vitasek R; Bartoskova A; Cizek P; Prinosilova P; Novakova K
Theriogenology; 2015 Apr; 83(7):1188-93. PubMed ID: 25617987
[TBL] [Abstract][Full Text] [Related]
20. Effects of long-term release GnRH agonist "deslorelin" on testicular HSP expression, accessory sex glands and testicular functions in adult male rats.
Eşki F; Çetin N; Uslu S; Uslu BA; Şendağ S; Yörük M; Naseer Z; Wehrend A; Shakeel M
Theriogenology; 2019 Aug; 134():104-111. PubMed ID: 31158733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
